25 XP   0   0   10

Vectus Biosystems Ltd
Buy, Hold or Sell?

Let's analyse Vectus Biosystems Ltd together

PenkeI guess you are interested in Vectus Biosystems Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vectus Biosystems Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vectus Biosystems Ltd

I send you an email if I find something interesting about Vectus Biosystems Ltd.

Quick analysis of Vectus Biosystems Ltd (30 sec.)










What can you expect buying and holding a share of Vectus Biosystems Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.19
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$0.07
Expected worth in 1 year
A$0.66
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$0.90
Return On Investment
327.4%

For what price can you sell your share?

Current Price per Share
A$0.28
Expected price per share
A$0.24 - A$0.295
How sure are you?
50%

1. Valuation of Vectus Biosystems Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.28

Intrinsic Value Per Share

A$-0.60 - A$-0.28

Total Value Per Share

A$-0.54 - A$-0.21

2. Growth of Vectus Biosystems Ltd (5 min.)




Is Vectus Biosystems Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$2.2m-$2.8m$5.1m225.5%

How much money is Vectus Biosystems Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$2.5m$349.8k15.8%
Net Profit Margin-254.6%-307.2%--

How much money comes from the company's main activities?

3. Financial Health of Vectus Biosystems Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#815 / 1014

Most Revenue
#513 / 1014

Most Profit
#318 / 1014

Most Efficient
#665 / 1014

What can you expect buying and holding a share of Vectus Biosystems Ltd? (5 min.)

Welcome investor! Vectus Biosystems Ltd's management wants to use your money to grow the business. In return you get a share of Vectus Biosystems Ltd.

What can you expect buying and holding a share of Vectus Biosystems Ltd?

First you should know what it really means to hold a share of Vectus Biosystems Ltd. And how you can make/lose money.

Speculation

The Price per Share of Vectus Biosystems Ltd is A$0.275. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vectus Biosystems Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vectus Biosystems Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.07. Based on the TTM, the Book Value Change Per Share is A$0.15 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vectus Biosystems Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.04-15.1%-0.04-15.1%-0.05-17.5%-0.04-14.3%-0.04-12.7%
Usd Book Value Change Per Share0.1034.9%0.1034.9%-0.02-6.7%0.015.1%0.001.1%
Usd Dividend Per Share0.0517.7%0.0517.7%0.0518.0%0.0518.7%0.039.3%
Usd Total Gains Per Share0.1452.6%0.1452.6%0.0311.3%0.0723.7%0.0310.5%
Usd Price Per Share0.28-0.28-0.63-0.49-0.48-
Price to Earnings Ratio-6.79--6.79--13.12--12.16--12.05-
Price-to-Total Gains Ratio1.95-1.95-20.37-5.40--2.78-
Price to Book Ratio6.64-6.64--11.85--8.11-59.78-
Price-to-Total Gains Ratio1.95-1.95-20.37-5.40--2.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1765775
Number of shares5663
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.05
Usd Book Value Change Per Share0.100.01
Usd Total Gains Per Share0.140.07
Gains per Quarter (5663 shares)818.51369.74
Gains per Year (5663 shares)3,274.031,478.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111022172326411633161469
222054344653823266322948
333076515981234899484427
44409868713086465212645906
555111085916360581515807385
666141303119634697818968864
7771615202229088141221210343
8881817374261829304252811822
99920195462945610467284413301
1011023217183273011630316014780

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.02.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%4.08.00.033.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%4.00.06.040.0%4.00.08.033.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%5.05.00.050.0%6.06.00.050.0%

Fundamentals of Vectus Biosystems Ltd

About Vectus Biosystems Ltd

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for cardiovascular fibrosis and systolic blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure; VB4-A32 for the treatment of liver fibrosis; and VB4-A79 for the treatment of lung fibrosis. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops Accugen consisting of AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in North Ryde, Australia.

Fundamental data was last updated by Penke on 2024-04-04 06:57:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vectus Biosystems Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vectus Biosystems Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -254.6% means that $-2.55 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vectus Biosystems Ltd:

  • The MRQ is -254.6%. The company is making a huge loss. -2
  • The TTM is -254.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-254.6%TTM-254.6%0.0%
TTM-254.6%YOY-307.2%+52.6%
TTM-254.6%5Y-575,492.0%+575,237.3%
5Y-575,492.0%10Y-308,781.7%-266,710.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-254.6%-196.1%-58.5%
TTM-254.6%-211.9%-42.7%
YOY-307.2%-277.7%-29.5%
5Y-575,492.0%-432.9%-575,059.1%
10Y-308,781.7%-599.3%-308,182.4%
1.1.2. Return on Assets

Shows how efficient Vectus Biosystems Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • -74.5% Return on Assets means that Vectus Biosystems Ltd generated $-0.74 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vectus Biosystems Ltd:

  • The MRQ is -74.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -74.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-74.5%TTM-74.5%0.0%
TTM-74.5%YOY-101.5%+27.0%
TTM-74.5%5Y-230.8%+156.3%
5Y-230.8%10Y-328.8%+98.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-74.5%-13.3%-61.2%
TTM-74.5%-12.7%-61.8%
YOY-101.5%-11.8%-89.7%
5Y-230.8%-14.0%-216.8%
10Y-328.8%-15.9%-312.9%
1.1.3. Return on Equity

Shows how efficient Vectus Biosystems Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • -97.9% Return on Equity means Vectus Biosystems Ltd generated $-0.98 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vectus Biosystems Ltd:

  • The MRQ is -97.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -97.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-97.9%TTM-97.9%0.0%
TTM-97.9%YOY--97.9%
TTM-97.9%5Y-19.6%-78.3%
5Y-19.6%10Y-610.0%+590.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-97.9%-16.9%-81.0%
TTM-97.9%-16.0%-81.9%
YOY--15.1%+15.1%
5Y-19.6%-19.7%+0.1%
10Y-610.0%-20.5%-589.5%

1.2. Operating Efficiency of Vectus Biosystems Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vectus Biosystems Ltd is operating .

  • Measures how much profit Vectus Biosystems Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • An Operating Margin of -339.4% means the company generated $-3.39  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vectus Biosystems Ltd:

  • The MRQ is -339.4%. The company is operating very inefficient. -2
  • The TTM is -339.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-339.4%TTM-339.4%0.0%
TTM-339.4%YOY-353.9%+14.4%
TTM-339.4%5Y-639,498.8%+639,159.3%
5Y-639,498.8%10Y-350,307.6%-289,191.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-339.4%-290.9%-48.5%
TTM-339.4%-224.4%-115.0%
YOY-353.9%-288.3%-65.6%
5Y-639,498.8%-479.5%-639,019.3%
10Y-350,307.6%-625.2%-349,682.4%
1.2.2. Operating Ratio

Measures how efficient Vectus Biosystems Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.39 means that the operating costs are $3.39 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 3.394. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.394. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.394TTM3.3940.000
TTM3.394YOY3.539-0.144
TTM3.3945Y5,892.208-5,888.814
5Y5,892.20810Y3,252.845+2,639.363
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3943.110+0.284
TTM3.3943.266+0.128
YOY3.5393.783-0.244
5Y5,892.2085.657+5,886.551
10Y3,252.8457.783+3,245.062

1.3. Liquidity of Vectus Biosystems Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vectus Biosystems Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.14 means the company has $4.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 4.142. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.142. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.142TTM4.1420.000
TTM4.142YOY0.504+3.638
TTM4.1425Y2.183+1.959
5Y2.18310Y4.257-2.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1423.905+0.237
TTM4.1424.212-0.070
YOY0.5045.337-4.833
5Y2.1836.062-3.879
10Y4.2576.401-2.144
1.3.2. Quick Ratio

Measures if Vectus Biosystems Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 4.07 means the company can pay off $4.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 4.075. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.075. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.075TTM4.0750.000
TTM4.075YOY0.487+3.588
TTM4.0755Y2.130+1.945
5Y2.13010Y4.646-2.516
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0753.572+0.503
TTM4.0754.001+0.074
YOY0.4875.364-4.877
5Y2.1306.009-3.879
10Y4.6466.287-1.641

1.4. Solvency of Vectus Biosystems Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vectus Biosystems Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vectus Biosystems Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24 means that Vectus Biosystems Ltd assets are financed with 23.9% credit (debt) and the remaining percentage (100% - 23.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 0.239. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.239. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.239TTM0.2390.000
TTM0.239YOY2.123-1.884
TTM0.2395Y5.446-5.207
5Y5.44610Y4.173+1.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2390.336-0.097
TTM0.2390.334-0.095
YOY2.1230.271+1.852
5Y5.4460.366+5.080
10Y4.1730.389+3.784
1.4.2. Debt to Equity Ratio

Measures if Vectus Biosystems Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 31.4% means that company has $0.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 0.314. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.314. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.314TTM0.3140.000
TTM0.314YOY-+0.314
TTM0.3145Y0.063+0.251
5Y0.06310Y1.761-1.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3140.382-0.068
TTM0.3140.397-0.083
YOY-0.341-0.341
5Y0.0630.432-0.369
10Y1.7610.465+1.296

2. Market Valuation of Vectus Biosystems Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vectus Biosystems Ltd generates.

  • Above 15 is considered overpriced but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A PE ratio of -6.79 means the investor is paying $-6.79 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vectus Biosystems Ltd:

  • The EOD is -4.243. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.788. Based on the earnings, the company is expensive. -2
  • The TTM is -6.788. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.243MRQ-6.788+2.546
MRQ-6.788TTM-6.7880.000
TTM-6.788YOY-13.123+6.335
TTM-6.7885Y-12.161+5.373
5Y-12.16110Y-12.045-0.116
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.243-2.262-1.981
MRQ-6.788-2.599-4.189
TTM-6.788-2.674-4.114
YOY-13.123-4.133-8.990
5Y-12.161-6.258-5.903
10Y-12.045-6.171-5.874
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vectus Biosystems Ltd:

  • The EOD is -6.174. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.879. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.879. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.174MRQ-9.879+3.705
MRQ-9.879TTM-9.8790.000
TTM-9.879YOY-11.746+1.866
TTM-9.8795Y-14.768+4.889
5Y-14.76810Y-15.226+0.459
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.174-2.913-3.261
MRQ-9.879-3.275-6.604
TTM-9.879-3.508-6.371
YOY-11.746-5.620-6.126
5Y-14.768-8.306-6.462
10Y-15.226-8.854-6.372
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vectus Biosystems Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.64 means the investor is paying $6.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vectus Biosystems Ltd:

  • The EOD is 4.153. Based on the equity, the company is fair priced.
  • The MRQ is 6.645. Based on the equity, the company is overpriced. -1
  • The TTM is 6.645. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.153MRQ6.645-2.492
MRQ6.645TTM6.6450.000
TTM6.645YOY-11.854+18.498
TTM6.6455Y-8.109+14.753
5Y-8.10910Y59.780-67.888
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.1531.858+2.295
MRQ6.6452.090+4.555
TTM6.6452.091+4.554
YOY-11.8542.866-14.720
5Y-8.1093.488-11.597
10Y59.7803.836+55.944
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vectus Biosystems Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vectus Biosystems Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1490.1490%-0.029+119%0.022+587%0.005+3018%
Book Value Per Share--0.0660.0660%-0.083+225%-0.054+181%-0.003+104%
Current Ratio--4.1424.1420%0.504+722%2.183+90%4.257-3%
Debt To Asset Ratio--0.2390.2390%2.123-89%5.446-96%4.173-94%
Debt To Equity Ratio--0.3140.3140%-+100%0.063+400%1.761-82%
Dividend Per Share--0.0760.0760%0.077-2%0.080-5%0.040+90%
Eps---0.065-0.0650%-0.075+16%-0.061-5%-0.055-16%
Free Cash Flow Per Share---0.045-0.0450%-0.084+88%-0.053+19%-0.047+6%
Free Cash Flow To Equity Per Share--0.0310.0310%-0.085+369%0.011+187%0.003+886%
Gross Profit Margin--1.4821.4820%1.328+12%1.313+13%1.157+28%
Intrinsic Value_10Y_max---0.276--------
Intrinsic Value_10Y_min---0.602--------
Intrinsic Value_1Y_max---0.048--------
Intrinsic Value_1Y_min---0.063--------
Intrinsic Value_3Y_max---0.128--------
Intrinsic Value_3Y_min---0.188--------
Intrinsic Value_5Y_max---0.190--------
Intrinsic Value_5Y_min---0.311--------
Market Cap14632585.000-60%23412136.00023412136.0000%52411259.000-55%40811609.800-43%39614398.300-41%
Net Profit Margin---2.546-2.5460%-3.072+21%-5754.920+225924%-3087.817+121174%
Operating Margin---3.394-3.3940%-3.539+4%-6394.988+188297%-3503.076+103101%
Operating Ratio--3.3943.3940%3.539-4%5892.208-100%3252.845-100%
Pb Ratio4.153-60%6.6456.6450%-11.854+278%-8.109+222%59.780-89%
Pe Ratio-4.243+38%-6.788-6.7880%-13.123+93%-12.161+79%-12.045+77%
Price Per Share0.275-60%0.4400.4400%0.985-55%0.767-43%0.745-41%
Price To Free Cash Flow Ratio-6.174+38%-9.879-9.8790%-11.746+19%-14.768+49%-15.226+54%
Price To Total Gains Ratio1.222-60%1.9551.9550%20.368-90%5.397-64%-2.784+242%
Quick Ratio--4.0754.0750%0.487+738%2.130+91%4.646-12%
Return On Assets---0.745-0.7450%-1.015+36%-2.308+210%-3.288+341%
Return On Equity---0.979-0.9790%--100%-0.196-80%-6.100+523%
Total Gains Per Share--0.2250.2250%0.048+365%0.102+121%0.045+403%
Usd Book Value--2262441.9182262441.9180%-2839032.308+225%-1828384.502+181%-86977.839+104%
Usd Book Value Change Per Share--0.0960.0960%-0.018+119%0.014+587%0.003+3018%
Usd Book Value Per Share--0.0430.0430%-0.053+225%-0.034+181%-0.002+104%
Usd Dividend Per Share--0.0490.0490%0.049-2%0.051-5%0.026+90%
Usd Eps---0.042-0.0420%-0.048+16%-0.039-5%-0.035-16%
Usd Free Cash Flow---1521692.885-1521692.8850%-2865199.167+88%-1814548.145+19%-1612988.461+6%
Usd Free Cash Flow Per Share---0.029-0.0290%-0.054+88%-0.034+19%-0.030+6%
Usd Free Cash Flow To Equity Per Share--0.0200.0200%-0.054+369%0.007+187%0.002+886%
Usd Market Cap9395582.829-60%15032932.52615032932.5260%33653269.404-55%26205134.653-43%25436405.148-41%
Usd Price Per Share0.177-60%0.2830.2830%0.632-55%0.492-43%0.478-41%
Usd Profit---2214513.006-2214513.0060%-2564402.928+16%-2041486.319-8%-1838189.882-17%
Usd Revenue--869746.924869746.9240%834782.010+4%347530.461+150%283341.522+207%
Usd Total Gains Per Share--0.1450.1450%0.031+365%0.065+121%0.029+403%
 EOD+2 -6MRQTTM+0 -0YOY+25 -115Y+22 -1410Y+26 -10

4.2. Fundamental Score

Let's check the fundamental score of Vectus Biosystems Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.243
Price to Book Ratio (EOD)Between0-14.153
Net Profit Margin (MRQ)Greater than0-2.546
Operating Margin (MRQ)Greater than0-3.394
Quick Ratio (MRQ)Greater than14.075
Current Ratio (MRQ)Greater than14.142
Debt to Asset Ratio (MRQ)Less than10.239
Debt to Equity Ratio (MRQ)Less than10.314
Return on Equity (MRQ)Greater than0.15-0.979
Return on Assets (MRQ)Greater than0.05-0.745
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Vectus Biosystems Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.693
Ma 20Greater thanMa 500.252
Ma 50Greater thanMa 1000.272
Ma 100Greater thanMa 2000.288
OpenGreater thanClose0.250
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Total Stockholder Equity -3,730-2,981-6,7103,811-2,899-1,522-4,4217,9453,524
Net Debt  1,9153,6815,596-2,6932,9042,7185,622-8,503-2,881
Other Stockholders Equity  11,0651,066-531,013-126887-3,608-2,720
Net Tangible Assets  -3,730-1,915-5,6452,822-2,823-711-3,5347,0573,524



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets4,630
Total Liabilities1,106
Total Stockholder Equity3,524
 As reported
Total Liabilities 1,106
Total Stockholder Equity+ 3,524
Total Assets = 4,630

Assets

Total Assets4,630
Total Current Assets4,457
Long-term Assets173
Total Current Assets
Cash And Cash Equivalents 2,951
Net Receivables 1,434
Inventory 1
Other Current Assets 71
Total Current Assets  (as reported)4,457
Total Current Assets  (calculated)4,457
+/-0
Long-term Assets
Property Plant Equipment 173
Long-term Assets  (as reported)173
Long-term Assets  (calculated)173
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,076
Long-term Liabilities30
Total Stockholder Equity3,524
Total Current Liabilities
Short-term Debt 43
Accounts payable 220
Other Current Liabilities 814
Total Current Liabilities  (as reported)1,076
Total Current Liabilities  (calculated)1,076
+/-0
Long-term Liabilities
Long term Debt Total 27
Other Liabilities 3
Long-term Liabilities  (as reported)30
Long-term Liabilities  (calculated)30
+/- 0
Total Stockholder Equity
Common Stock38,352
Retained Earnings -35,632
Accumulated Other Comprehensive Income 803
Total Stockholder Equity (as reported)3,524
Total Stockholder Equity (calculated)3,524
+/-0
Other
Capital Stock38,352
Cash and Short Term Investments 2,951
Common Stock Shares Outstanding 47,952
Current Deferred Revenue453
Liabilities and Stockholders Equity 4,630
Net Debt -2,881
Net Invested Capital 3,524
Net Tangible Assets 3,524
Net Working Capital 3,381
Property Plant and Equipment Gross 897
Short Long Term Debt Total 70



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-30
> Total Assets 
673
1,491
718
11,729
4,685
721
196
194
2,998
6,979
3,936
4,630
4,6303,9366,9792,9981941967214,68511,7297181,491673
   > Total Current Assets 
0
0
523
11,669
4,600
654
150
159
2,919
6,906
3,729
4,457
4,4573,7296,9062,9191591506544,60011,66952300
       Cash And Cash Equivalents 
341
1,257
70
11,585
421
517
42
43
2,685
5,778
1,281
2,951
2,9511,2815,7782,685434251742111,585701,257341
       Short-term Investments 
0
0
402
34
4,034
0
0
31
31
0
0
0
0003131004,0343440200
       Net Receivables 
48
16
51
50
96
78
25
32
79
977
2,318
1,434
1,4342,318977793225789650511648
       Inventory 
0
0
0
0
0
0
0
0
46
-827
0
1
10-8274600000000
   > Long-term Assets 
0
0
0
60
84
66
46
35
79
73
208
173
17320873793546668460000
       Property Plant Equipment 
277
217
195
60
84
66
46
35
79
73
208
173
17320873793546668460195217277
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
000000000000
> Total Liabilities 
1,177
516
662
511
936
604
2,453
3,924
9,709
9,878
8,358
1,106
1,1068,3589,8789,7093,9242,4536049365116625161,177
   > Total Current Liabilities 
463
457
590
476
904
593
2,440
1,962
1,447
1,655
7,398
1,076
1,0767,3981,6551,4471,9622,440593904476590457463
       Short-term Debt 
0
0
47
26
5
0
912
4
21
461
5,946
43
435,94646121491205264700
       Short Long Term Debt 
0
0
47
26
5
0
912
0
0
442
5,890
0
05,8904420091205264700
       Accounts payable 
134
118
302
156
330
74
981
1,120
606
328
120
220
2201203286061,12098174330156302118134
       Other Current Liabilities 
289
299
266
304
569
265
266
544
805
845
1,304
814
8141,304845805544266265569304266299289
   > Long-term Liabilities 
0
0
0
35
32
11
13
1,962
8,261
8,223
959
30
309598,2238,2611,96213113235000
       Long term Debt Total 
0
0
0
0
0
0
0
1,958
7,195
7,208
70
27
27707,2087,1951,9580000000
       Capital Lease Obligations Min Short Term Debt
0
0
-47
-26
0
0
-912
5
35
-425
-5,819
27
27-5,819-425355-91200-26-4700
> Total Stockholder Equity
0
975
56
11,218
3,749
117
-2,256
-3,730
-6,710
-2,899
-4,421
3,524
3,524-4,421-2,899-6,710-3,730-2,2561173,74911,218569750
   Retained Earnings -35,632-32,183-28,189-24,843-21,848-20,251-17,663-13,869-10,658-9,00200
   Accumulated Other Comprehensive Income 
0
0
0
0
36
188
394
517
271
455
459
803
803459455271517394188360000
   Capital Surplus 000000000000
   Treasury Stock000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue1,355
Cost of Revenue-47
Gross Profit1,3071,307
 
Operating Income (+$)
Gross Profit1,307
Operating Expense-4,551
Operating Income-4,598-3,243
 
Operating Expense (+$)
Research Development1,958
Selling General Administrative2,571
Selling And Marketing Expenses1,662
Operating Expense4,5516,191
 
Net Interest Income (+$)
Interest Income56
Interest Expense-206
Other Finance Cost-0
Net Interest Income-150
 
Pretax Income (+$)
Operating Income-4,598
Net Interest Income-150
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,737-4,459
EBIT - interestExpense = -4,803
-4,737
-3,243
Interest Expense206
Earnings Before Interest and Taxes (EBIT)-4,598-4,532
Earnings Before Interest and Taxes (EBITDA)-4,551
 
After tax Income (+$)
Income Before Tax-4,737
Tax Provision-0
Net Income From Continuing Ops-3,449-4,737
Net Income-3,449
Net Income Applicable To Common Shares-3,449
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,598
Total Other Income/Expenses Net-139150
 

Technical Analysis of Vectus Biosystems Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vectus Biosystems Ltd. The general trend of Vectus Biosystems Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vectus Biosystems Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vectus Biosystems Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.285 < 0.295 < 0.295.

The bearish price targets are: 0.24 > 0.24 > 0.24.

Tweet this
Vectus Biosystems Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vectus Biosystems Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vectus Biosystems Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vectus Biosystems Ltd. The current macd is -0.00414722.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vectus Biosystems Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vectus Biosystems Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vectus Biosystems Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vectus Biosystems Ltd Daily Moving Average Convergence/Divergence (MACD) ChartVectus Biosystems Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vectus Biosystems Ltd. The current adx is 12.21.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vectus Biosystems Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Vectus Biosystems Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vectus Biosystems Ltd. The current sar is 0.23881743.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vectus Biosystems Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vectus Biosystems Ltd. The current rsi is 55.69. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Vectus Biosystems Ltd Daily Relative Strength Index (RSI) ChartVectus Biosystems Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vectus Biosystems Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vectus Biosystems Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vectus Biosystems Ltd Daily Stochastic Oscillator ChartVectus Biosystems Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vectus Biosystems Ltd. The current cci is 125.27.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Vectus Biosystems Ltd Daily Commodity Channel Index (CCI) ChartVectus Biosystems Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vectus Biosystems Ltd. The current cmo is 21.07.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vectus Biosystems Ltd Daily Chande Momentum Oscillator (CMO) ChartVectus Biosystems Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vectus Biosystems Ltd. The current willr is -22.22222222.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vectus Biosystems Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vectus Biosystems Ltd Daily Williams %R ChartVectus Biosystems Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vectus Biosystems Ltd. The current atr is 0.01202167.

Vectus Biosystems Ltd Daily Average True Range (ATR) ChartVectus Biosystems Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vectus Biosystems Ltd. The current obv is -1,369,824.

Vectus Biosystems Ltd Daily On-Balance Volume (OBV) ChartVectus Biosystems Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vectus Biosystems Ltd. The current mfi is 17.50.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Vectus Biosystems Ltd Daily Money Flow Index (MFI) ChartVectus Biosystems Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vectus Biosystems Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Vectus Biosystems Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vectus Biosystems Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.693
Ma 20Greater thanMa 500.252
Ma 50Greater thanMa 1000.272
Ma 100Greater thanMa 2000.288
OpenGreater thanClose0.250
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vectus Biosystems Ltd with someone you think should read this too:
  • Are you bullish or bearish on Vectus Biosystems Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vectus Biosystems Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vectus Biosystems Ltd

I send you an email if I find something interesting about Vectus Biosystems Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Vectus Biosystems Ltd.

Receive notifications about Vectus Biosystems Ltd in your mailbox!